Publications by authors named "Vikrant Rahi"

Introduction: Ischemic stroke (IS), a major cause of mortality and disability worldwide, remains a significant healthcare challenge due to limited therapeutic options. Ferroptosis, a distinct iron-dependent form of regulated cell death characterized by lipid peroxidation and oxidative stress, has emerged as a crucial mechanism in IS pathophysiology. This review explores the role of ferroptosis in IS and its potential for driving innovative therapeutic strategies.

View Article and Find Full Text PDF

Calcium ion (Ca) dysregulation is one of the main causes of neuronal cell death and brain damage after cerebral ischemia. During ischemic stroke, the ability of neurons to maintain Ca homeostasis is compromised. Ca regulates various functions of the nervous system, including neuronal activity and adenosine triphosphate (ATP) production.

View Article and Find Full Text PDF

Animal models are used to better understand the various mechanisms involved in the pathogenesis of diseases and explore potential pathways that will aid in discovering therapeutic targets. 3-Nitropropionic Acid (3-NPA) is a neurotoxin used to induce Huntington's disease (HD)-like symptoms in experimental animals. The 3-NPA is a fungus toxin that impairs the complex II (succinate dehydrogenase) activity of the mitochondria and reduces ATP synthesis, leading to excessive production of free radicals resulting in the degeneration of GABAergic medium spiny neurons (MSNs) in the striatum.

View Article and Find Full Text PDF

(HD) Huntington's disease is a severe hereditary catastrophic neurological disease with an autosomal dominant heritable changes manifested by cognitive, behavioural, and motor progression deficits, resulting in death. Several mechanisms are involved in the pathogenesis of this complex and rare disease, including excitotoxicity, mitochondrial dysfunction, neurotransmitters imbalance, and oxidative stress. Silymarin was selected as an investigational drug, due to its numerous activities in current research, it possesses substantial antioxidant and neuroprotective functionalities.

View Article and Find Full Text PDF

Striatal neurotoxicity is the pathological hallmark for a heterogeneous group of movement disorders like Tardive dyskinesia (TD) and Huntington's disease (HD). Both diseases are characterized by progressive impairment in motor function. TD and HD share common features at both cellular and subcellular levels.

View Article and Find Full Text PDF

Berberine due to its antioxidant properties, has been used around the globe significantly to treat several brain disorders. Also, oxidative stress is a pathological hallmark in neurodegenerative diseases like Huntington's disease (HD) and Tardive dyskinesia (TD). Berberine an alkaloid from plants has been reported to have neuroprotective potential in several animal models of neurodegenerative diseases.

View Article and Find Full Text PDF

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) known as coronavirus disease (COVID-19), emerged in Wuhan, China, in December 2019. On March 11, 2020, it was declared a global pandemic. As the world grapples with COVID-19 and the paucity of clinically meaningful therapies, attention has been shifted to modalities that may aid in immune system strengthening.

View Article and Find Full Text PDF

Attention-deficit hyperactivity disorder (ADHD) is a heterogeneous neuropsychiatric disorder characterized by three primary symptoms hyperactivity, attention deficit, and impulsiveness, observed in both children and adults. In childhood, this disorder is more common in boys than in girls, and at least 75% will continue to suffer from the disorder until adulthood. Individuals with ADHD generally have poor academic, occupational, and social functioning resulting from developmentally inappropriate levels of hyperactivity and impulsivity, as well as impaired ability to maintain attention on motivationally relevant tasks.

View Article and Find Full Text PDF
Article Synopsis
  • G-CSF (Granulocyte-colony stimulating factor) is a 19.6 kDa glycoprotein that plays a vital role in the growth and survival of neutrophil cells, crucial for the immune system.
  • It has been clinically used to treat low white blood cell counts due to chemotherapy, but recent research suggests it may also protect neurons and promote brain health by mobilizing stem cells and reducing inflammation.
  • The review aims to summarize G-CSF's neuroprotective mechanisms and potential clinical applications for neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s disease.
View Article and Find Full Text PDF
Article Synopsis
  • The text discusses the emerging potential of gene therapy and immunotherapy as treatments for Huntington's Disease (HD), highlighting interest in these approaches for modulating gene expression and immune activation.
  • It covers current research and trials focused on RNA and DNA therapies aimed at reducing mutant huntingtin protein, which is linked to HD, and notes the discovery of new therapeutic targets driven by better understanding of the disease's mechanisms.
  • The review emphasizes safety and efficacy, shifting towards disease-modifying therapies while outlining future directions for targeted gene and immunotherapy to address HD at both the genetic and protein levels.
View Article and Find Full Text PDF

Chronic fatigue syndrome (CFS) is a disorder characterized by persistent and relapsing fatigue along with long-lasting and debilitating fatigue, myalgia, cognitive impairment, and many other common symptoms. The present study was conducted to explore the protective effect of hemin on CFS in experimental mice. Male albino mice were subjected to stress-induced CFS in a forced swimming test apparatus for 21 days.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Vikrant Rahi"

  • - Vikrant Rahi's recent research primarily focuses on neurodegenerative diseases, specifically investigating the mechanisms of neuronal damage and potential therapeutic interventions, particularly in the context of Huntington's disease and ischemic stroke.
  • - One significant finding illustrates how calcium dysregulation during ischemic stroke contributes to neuronal cell death, supporting a need for therapies that maintain calcium homeostasis in neuronal cells.
  • - Additionally, Rahi explores the neuroprotective effects of various compounds, such as silymarin and berberine, highlighting their potential in mitigating neurotoxicity induced by neurotoxic agents like 3-Nitropropionic Acid, further emphasizing the role of oxidative stress in neurodegenerative pathologies.